- Home
- ASMB vs FFIE Comparison
ASMB vs FFIE Comparison
Compare ASMB & FFIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASMB
- FFIE
- Stock Information
- Founded
- ASMB 2005
- FFIE 2014
- Country
- ASMB United States
- FFIE United States
- Employees
- ASMB N/A
- FFIE N/A
- Industry
- ASMB Biotechnology: Pharmaceutical Preparations
- FFIE Auto Manufacturing
- Sector
- ASMB Health Care
- FFIE Consumer Discretionary
- Exchange
- ASMB Nasdaq
- FFIE Nasdaq
- Market Cap
- ASMB 92.1M
- FFIE 97.5M
- IPO Year
- ASMB 2010
- FFIE N/A
- Fundamental
- Price
- ASMB $13.61
- FFIE $1.36
- Analyst Decision
- ASMB Buy
- FFIE
- Analyst Count
- ASMB 2
- FFIE 0
- Target Price
- ASMB $35.00
- FFIE N/A
- AVG Volume (30 Days)
- ASMB 25.5K
- FFIE 13.3M
- Earning Date
- ASMB 03-27-2025
- FFIE 11-06-2024
- Dividend Yield
- ASMB N/A
- FFIE N/A
- EPS Growth
- ASMB N/A
- FFIE N/A
- EPS
- ASMB N/A
- FFIE N/A
- Revenue
- ASMB $28,326,000.00
- FFIE $537,000.00
- Revenue This Year
- ASMB $282.16
- FFIE $10,958.67
- Revenue Next Year
- ASMB N/A
- FFIE $617.65
- P/E Ratio
- ASMB N/A
- FFIE N/A
- Revenue Growth
- ASMB N/A
- FFIE N/A
- 52 Week Low
- ASMB $9.84
- FFIE $0.99
- 52 Week High
- ASMB $19.93
- FFIE $156.00
- Technical
- Relative Strength Index (RSI)
- ASMB 39.96
- FFIE 44.01
- Support Level
- ASMB $13.76
- FFIE $1.30
- Resistance Level
- ASMB $14.67
- FFIE $1.54
- Average True Range (ATR)
- ASMB 0.72
- FFIE 0.16
- MACD
- ASMB -0.09
- FFIE -0.04
- Stochastic Oscillator
- ASMB 2.03
- FFIE 26.09
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
About FFIE Faraday Future Intelligent Electric Inc.
Faraday Future Intelligent Electric Inc is a global shared intelligent mobility ecosystem. It is poised to break the boundaries between the Internet, IT, creative, and auto industries with product and service offerings that integrate new energy, AI, Internet, and sharing models.